926 related articles for article (PubMed ID: 7097683)
1. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
4. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
5. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
7. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
8. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
9. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
10. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ro/SSA and La/SSB antibodies.
Franceschini F; Cavazzana I
Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
13. Predicting Sjögren's syndrome in patients with recent-onset SLE.
Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
[TBL] [Abstract][Full Text] [Related]
14. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
15. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.
Yao Q; Altman RD; Wang X
J Clin Rheumatol; 2012 Jan; 18(1):28-32. PubMed ID: 22157271
[TBL] [Abstract][Full Text] [Related]
20. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]